Shanxi Tianli Hengde Pharmaceutical Technology Co., Ltd. signed an equity transfer agreement to acquire 51% stake in Shanxi Jianghe Tonghui Medical Equipment Co., Ltd. from Thalys Medical Technology Group Corporation (SHSE:603716) for CNY 0.55 million in March 2023.
Thalys Medical Technology Group Corporation
Equities
603716
CNE1000030C3
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
7.15 CNY | +1.13% | -2.59% | -35.53% |
1st Jan change | Capi. | |
---|---|---|
-35.53% | 185M | |
-3.28% | 9.41B | |
-0.02% | 1.44B | |
-8.15% | 1.38B | |
-13.57% | 1.11B | |
-18.54% | 873M | |
-1.34% | 463M | |
+2.71% | 440M | |
-23.11% | 348M | |
-3.34% | 211M |
- Stock Market
- Equities
- 603716 Stock
- News Thalys Medical Technology Group Corporation
- Shanxi Tianli Hengde Pharmaceutical Technology Co., Ltd. signed an equity transfer agreement to acquire 51% stake in Shanxi Jianghe Tonghui Medical Equipment Co., Ltd. from Thalys Medical Technology Group Corporation for CNY 0.55 million.